Once daily oral treatment for adults with chronic idiopathic constipation.

A selective serotonin-4 (5 HT4) receptor agonist that enhances colonic peristalsis to increase bowel motility.

Increases intracellular adenosine monophosphate to enhance release of as acetylcholine, major excitatory neurotransmitter in the G.I. tract.

In 6 studies 19-38% of patients who receive the drug responded compared with 10%-20% of those who received a placebo.

Common adverse reactions include: headache, abdominal pain, nausea, diarrhea, and abdominal distention.

The usual recommended dose is 2 mg daily in individual 65 years or younger and 1 mg daily in individuals older than 65 years.

It is eliminated exclusively through renal excretion.

It should be used only if standard laxatives fail for the management of constipation.

One reply on “Prucalopride”

Leave a Reply

Your email address will not be published. Required fields are marked *